Aetna 2004 Annual Report Download - page 23

Download and view the complete annual report

Please find page 23 of the 2004 Aetna annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 25

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25

43
Mr. Jordan at P.O. Box 370205,
West Hartford, CT 06137-0205.
All communications will be kept
confidential and forwarded directly
to the Presiding Director or Board,
as applicable. To contact Aetnas
management Directors, you may
write to Dr. Rowe at Aetna Inc.,
151 Farmington Avenue,
Hartford, CT 06156.
Aetna mails quarterly financial
results only to those shareholders
who request copies. Shareholders
may call 1-800-237-4273 to listen
to the Companys quarterly earnings
release and dividend information,
and to request faxed or mailed
copies of the quarterly results.
CERTIFICATIONS
John W. Rowe, M.D., Chief
Executive Officer, and Alan M.
Bennett, Chief Financial Officer,
have provided unqualified
Certifications of the Company’s
public disclosure contained in the
Companys Annual Report on
Form 10-K for the year ended
December 31, 2004 (the “2004
Form 10-K”), filed with the SEC.
These Certifications, which are
required pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002
and related regulations, are filed as
exhibits to the 2004 Form 10-K.
In addition, NYSE regulations
require that the Chief Executive
Officer provide the NYSE each
year with a certification of
compliance with the NYSE’s
corporate governance listing
standards following the annual
shareholders meeting. As required
by these regulations, in May 2004,
Dr. Rowe provided the NYSE
with an unqualified certification
regarding compliance with these
standards.
INVESTOR RELATIONS
Securities analysts and institutional
investors should contact:
David W. Entrekin
Vice President
Phone: 860-273-7830
Fax: 860-273-3971
E-mail address:
SHAREHOLDER SERVICES
EquiServe Trust Company, N.A.
(“EquiServe”) maintains a
telephone response center and a
Web site to service registered
shareholder accounts. Registered
shareholders may contact
EquiServe to inquire about
replacement dividend checks,
address changes, stock transfers
and other account matters.
DirectSERVICE Investment
Program
Current shareholders and new
investors can purchase Aetna
common shares and reinvest cash
dividends through this program
sponsored by EquiServe.
Contacting EquiServe by mail:
EquiServe Trust Company, N.A.
P.O. Box 43069
Providence, RI 02940-3069
Contacting EquiServe by telephone:
1-800-446-2617 – For
general inquiries and
dividend reinvestment
1-800-870-2340 – To enroll
in direct deposit of dividends
Contacting EquiServe via
Internet (instructions below):
http://www.equiserve.com
Current registered shareholder
access: Click “account access” to
log into your account. New users
can click “passwords and login
assistance” on the right side of the
login page to set up their access
and passwords for the first time.
New investors in the DirectSERVICE
Investment Program: Click
“buy stock direct” and search by
ticker symbol “AET” to view or
print the plan materials and/or to
open a new shareholder account
completely online.
Other Shareholder Inquiries
Office of the Corporate Secretary
Aetna Inc.
151 Farmington Avenue, RE4K
Hartford, CT 06156-3215
Phone: 860-273-4970
Fax: 860-293-1361
E-mail address:
AETNA STOCK OPTION
PARTICIPANTS AND
AETNA EMPLOYEE
STOCK PURCHASE PLAN
PARTICIPANTS
Employees with outstanding
stock options should address all
questions to UBS Financial
Services, Inc. (“UBS”) regarding
their accounts, outstanding
options or shares received through
option exercises. Employees
participating in the Employee
Stock Purchase Plan also should
contact UBS with questions on
their accounts.
UBS Financial Services, Inc.
Corporate Employee
Financial Services
300 Lighting Way, 6th Floor
Secaucus, NJ 07094-3672
Phone: 1-888-793-7631
(TTY for the hearing impaired:
1-877-352-3595)
Online Access
http://www.ubs.com/onesource/aet
42
STOCK EXCHANGE LISTING
Aetna Inc.s (“Aetnas” or the
“Companys”) common shares are
listed on the New York Stock
Exchange (“NYSE”). The NYSE
symbol for the common shares is
AET. As of January 31, 2005,
there were 12,709 record holders
of Aetnas common shares.
WEB SITE ACCESS TO AETNA’S
PERIODIC AND CURRENT
REPORTS AND CORPORATE
GOVERNANCE MATERIALS
Aetna makes available free of
charge through its Web site at
http://www.aetna.com its
Annual Reports on Form 10-K,
Quarterly Reports on Form 10-Q,
Current Reports on Form 8-K and
all amendments to those reports
as soon as reasonably practicable
after Aetna electronically files or
furnishes such materials with the
U.S. Securities and Exchange
Commission (the “SEC”). Aetna
also makes available free of
charge through its Web site the
Companys Annual Report,
Financial Report to Shareholders
and Proxy Statement. Shareholders
may request printed copies of
these reports free of charge by
calling 1-800-237-4273.
Aetnas Annual Report on Form
10-K provides additional details
about the Companys business, as
well as other financial information
not included in this Annual
Report. To receive a copy of the
Annual Report on Form 10-K
without charge, please follow the
above instructions.
Also available on Aetnas Web site at
http://www.aetna.com/governance
are the following Aetna corporate
governance materials: Articles of
Incorporation and By-Laws; Code
of Conduct for Directors, officers
and employees (and information
regarding any amendments or
waivers relating to Aetnas Directors,
executive officers and principal
financial and accounting officers
or persons performing similar
functions); Independence Standards
for Directors; Corporate Governance
Guidelines; and Charters for the
key standing Committees of the
Board of Directors (Audit
Committee, Committee on
Compensation and Organization,
Executive Committee, Investment
and Finance Committee,
Medical Affairs Committee, and
Nominating and Corporate
Governance Committee).
These materials also are available
in print to shareholders free of
charge by calling 1-800-237-4273.
Section 16 reports are filed
with the SEC by Aetnas Directors
and those officers subject to
Section 16 to reflect a change
in their beneficial ownership of
Aetnas securities and are available
through Aetnas Web site at
http://www.aetna.com.
The Audit Committee of the
Board of Directors can be
confidentially contacted by those
wishing to raise concerns or
complaints about the Companys
accounting, internal accounting
controls or auditing matters by
calling AlertLine®
, an independent
toll-free service, at 1-888-891-8910
(available seven days a week,
24 hours a day), or by writing to:
Corporate Compliance,
P.O. Box 370205, West Hartford,
CT 06137-0205.
Anyone wishing to make their
concerns known to Aetnas
nonmanagement Directors or to
send a communication to the
entire Board of Directors may
contact Michael H. Jordan,
Aetnas Presiding Director, who,
among other things, presides
over both the nonmanagement
Directors’ and the independent
Directors’ sessions, by writing to
SHAREHOLDER
INFORMATION
ANNUAL MEETING
The annual meeting of
shareholders of Aetna Inc.
will be held on Friday,
April 29, 2005, at
10:00 a.m. at the
Four Seasons Hotel in
Philadelphia, Pennsylvania.
CORPORATE
HEADQUARTERS
151 Farmington Avenue
Hartford, CT 06156
Phone: 860-273-0123